Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;1(3):185-93.
doi: 10.1007/s13346-011-0024-4.

Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections

David R Friend  1
Affiliations

Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections

David R Friend. Drug Deliv Transl Res. 2011 Jun.

Abstract

Intravaginal rings (IVRs) are a dosage form used to locally or systemically deliver drugs in the vagina. They are capable of releasing one or more drugs over an extended period of time (from several weeks to a year or longer). Contraceptive IVRs are currently gaining popularity due to the success of the contraceptive product NuvaRing®. Delivery of contraceptives from IVRs should promote compliance/adherence, and they also provide effective cycle control and symptom relief (menorrhagia, dysmenorrheal, and polycystic ovarian syndrome). Vaginal delivery of proteins from IVRs was first explored in an attempt to deliver IgG2a antibody intravaginally to neutralize herpes simplex virus 2. More recently, IVRs capable of releasing antibodies and recombinant proteins potentially along with low molecular weight microbicides are under investigation for prevention of HIV-1 transmission. Vaginal delivery of microbicides has been studied with several drugs most notably the non-nucleoside reverse transcriptase inhibitor dapivirine. Another drug capable of blocking transmission of HIV-1 when released from IVRs is tenofovir. Finally, combinations of drugs with different indications (i.e., multipurpose prevention technologies) are actively being pursued.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Contraception. 2007 Aug;76(2):132-8 - PubMed
    1. Eur J Pharm Sci. 2010 Feb 19;39(4):203-12 - PubMed
    1. J Control Release. 1999 Sep 20;61(3):319-28 - PubMed
    1. Contraception. 2006 Dec;74(6):451-7 - PubMed
    1. AIDS. 2002 Jan 25;16(2):227-33 - PubMed

LinkOut - more resources

-